ESC 365 - Comparison of clinical and economic burden of pulmonary arterial hypertension patients with and without connective tissue disease treated with macitentan

ESC Professional Premium Access

Comparison of clinical and economic burden of pulmonary arterial hypertension patients with and without connective tissue disease treated with macitentan

Session: Hypertension - Treatment lifestyle and pharmacotherapy

Topic: Treatment

Speaker: Doctor C. Worden (Titusville, US)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Carly Worden

Janssen Pharmaceuticals, Titusville (United States of America)

0 follower

4 more presentations in this session

Persistence with macitentan versus other endothelin receptor antagonists in patients with pulmonary arterial hypertension: experience from a real-world data repository in the USA

Speaker: Doctor S. Panjabi (San Mateo, US)

Additional opportunities for antihypertensive therapy improvement in young patients with arterial hypertension and concomitant obesity

Speaker: Doctor K. Chernyshova (Odessa, UA)

The music therapy effectiveness in hypertensive patients with acute myocardial infarction after previous coronary artery bypass surgery; 18-year experience of the MUSIC study

Speaker: Professor P. Mitrovic (Belgrade, RS)

Angiotensin receptor blockers are equally effective in women and men; a systematic review and meta-analysis

Speaker: Mrs S. Laven (Maastricht, NL)

Access the full session

Hypertension - Treatment lifestyle and pharmacotherapy

Speakers: Doctor C. Worden, Doctor S. Panjabi, Doctor K. Chernyshova, Professor P. Mitrovic, Mrs S. Laven

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources